-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 21.2% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.6 million. As per the press release, Q3 earnings came out 3 days ago.
  • Insight Molecular (NASDAQ:IMDX) shares rose 17.0% to $2.08. The company's market cap stands at $58.3 million. The company's, Q3 earnings came out 2 days ago.
  • BioLine Rx (NASDAQ:BLRX) shares moved upwards by 16.07% to $1.3. The market value of their outstanding shares is at $5.5 million.
  • Faeth Therapeutics (NASDAQ:FTH) shares moved upwards by 14.82% to $10.38. The company's market cap stands at $233.0 million.
  • Neuronetics (NASDAQ:STIM) stock rose 13.28% to $1.45. The market value of their outstanding shares is at $123.4 million.
  • PMV Pharmaceuticals (NASDAQ:PMVP) stock rose 10.65% to $1.35. The market value of their outstanding shares is at $92.1 million.

Losers

  • Rafael Holdings (NYSE:RFL) shares fell 24.8% to $0.69 during Wednesday's pre-market session. The company's market cap stands at $47.6 million.
  • Iridex (NASDAQ:IRIX) shares fell 22.7% to $0.54. The market value of their outstanding shares is at $12.1 million. The company's, Q3 earnings came out yesterday.
  • Innate Pharma (NASDAQ:IPHA) shares fell 14.95% to $1.13. The market value of their outstanding shares is at $148.5 million.
  • Stablecoin Development (AMEX:SDEV) shares decreased by 13.36% to $0.6. The market value of their outstanding shares is at $50.9 million.
  • Alterity Therapeutics (NASDAQ:ATHE) shares fell 10.46% to $1.67. The market value of their outstanding shares is at $35.6 million.
  • XORTX Therapeutics (NASDAQ:XRTX) stock decreased by 10.21% to $0.95. The company's market cap stands at $2.3 million. The company's, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending